Mrs
Rachel
Fetches

Partner & Head of Law

London Office

Chemistry

Telephone. +44(0) 207 776 5111
Mobile. +44(0) 782 790 9139
Email. [email protected]

Experience

Rachel is an IP/Patent Litigation Partner and advises on contentious intellectual property matters for clients across a broad range of sectors including, life sciences, pharmaceuticals, healthcare, chemicals, food and beverage, aviation, media and telecommunications industries. She has extensive experience of litigating before the UK Patents Court, High Court and Court of Appeal. She has also regularly advised in relation to pan-European IP litigation strategy for both patents and trade marks. Rachel is currently leading HGF's UPC team.

Qualifications

Solicitor

England & Wales
Ireland
Republic of Ireland


BSC

Cell Biotechnology (Spec)

MA

Health Care Ethics

POSTGRADUATE DIPLOMA OR CERTIFICATE

Intellectual Property Law

OTHER

PgDL/LPC College of Law

Recognition

MIP Stars Handbook 2016

“Rachel is an accomplished patent litigator with an excellent pedigree in life sciences” says a peer

IAM Patent 1000

“Rachel Fetches is the woman to go to. Her weighty workload includes substantial matters such as representing Accord Healthcare against Research Technologies a complex case that has involved expert testimony from US federal law and Texas state law experts”

Legal500, London: Intellectual Property - patents (contentious and non-contentious)

HGF Limited’s patent litigators have strength in the life sciences sector, as evidenced by Rachel Fetches’ representation of multinational generic pharmaceuticals companies in patent infringement defence and oppositions.

View recognition online

Publications

Prominence given to the preservation of the status quo

View publication online

Blockbuster blood thinning patent revoked

View publication online

IPBC Europe 2022

View publication online

UPC could open its doors in 2022

View publication online

A new dawn for SPCs

View publication online

UK Supreme Court invalidates Regeneron's transgenic mouse patents for lack of sufficiency

View publication online

SKY Trade Marks applied for to use purely as “Legal Weapon” are held to be invalid

View publication online

HGF wins Scottish “Firm of the Year” for Prosecution at the MIP Awards

View publication online

The end of the UPC as we know it?

View publication online

SkyKick ruling

View publication online

Clearing out the clutter – SkyKick may open up trade mark registers Across Europe

View publication online

The Vedanta Opposition: A healthy sign of a maturing industry

View publication online

Test for obviousness for dosage patents clarified by the Supreme Court

View publication online

Conferences: 2022

October 6th 2022

UPC event in Ireland: Maintaining commercial relevance of your European IP strategy with the new Unified Patent Court system

Speaking

Event details

March 7th 2022

IQPC Global Exchange Europe 2022

Speaker

Event details

Conferences: 2021

March 2nd 2021

MIP International Patent Forum

Attended

Event details

February 9th 2021

HGF IP in Healthcare Virtual Conference

Speaker

Event details

January 14th 2021

HGF IP in Healthcare Virtual Conference 2021

Speaker

Event details

Conferences: 2020

November 2nd 2020

AIPPI Congress London

Attended

Event details

Conferences: 2019

November 26th 2019

IQPC Lifesciences in IP

Attended

Event details

November 26th 2019

IQPC Life Science IP 2019 - London

Attended

Event details

November 21st 2019

Life Sciences Patent Network

Attended

Event details

June 3rd 2019

2019 BIO International Convention - Philadelphia

Attended

Event details

March 19th 2019

HGF IP in Healthcare Conference

Speaker

Event details

March 14th 2019

IP in Healthcare Conference 2019 - London & Manchester

Speaker

Event details

Conferences: 2018

November 27th 2018

IQPC Life Sciences IP Conference

Speaker

Event details

Related News

Food technology companies and investors - the value of IP landscape analysis

Case study – alt fat innovation Many companies and investors are aware of the importance of identifying and protecting their innovations, and in particular of the importance of obtaining patents …

Read article
Event - 20th-23rd September 2022

MARQUES Annual Conference 2022

The 2022 MARQUES Annual Conference will be held in Madrid on 20-23 September. This year’s conference will focus on celebrating marks. The various sessions will address in particular how sustainability …

Event details
Event - 29th September 2022

North East Automotive Expo 2022

HGF will be exhibiting at The North East Automotive Alliance’s flagship Expo on 29th September 2022. The event is an industry highlight for companies operating within the region’s automotive supply …

Event details
Event - 22nd September 2022

WIPR Trademarks Los Angeles 2022

WIPR Trademarks Los Angeles will be held on 22nd September 2022. The event will bring together 100+ brand protection experts to discuss key strategic trademark management issues. WIPR Trademarks Los …

Event details
Event - 21st-22nd September 2022

Medical Technology Ireland 2022

Medical Technology Ireland Conference 2022 will be held on 21-22 September at the Galway Racecource. Medical Technology Ireland is a new high-profile National and International event attracting global suppliers to …

Event details

Who owns NFTs?

For any avid readers you may recall back in our Spring Retail Scanner we covered NFTs, specifically what they are and what they mean for retailers and their IP. In …

Read article

A question of refills but also one of trade marks

The case Advocate General Giovanni Pitruzzelli provided an Opinion on 12th May 2022 in a case being heard by the Court of Justice of the European Union (CJEU), originating from …

Read article

Ownership in the metaverse - a (virtual) reality or a real fiction?

A look at whether you own and control what you buy in the space. First things first, let’s define the metaverse The metaverse can be described as a network of …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.